Anti-Human PDGFRα Monoclonal Antibody (Olaratumab)
Platelet-derived growth factor receptor alpha,PDGF-R-alpha,PDGFR-alpha,Alpha platelet-derived growth factor receptor,Alpha-type platelet-derived growth factor receptor,CD140 antigen-like family member A,CD140a antigen,Platelet-derived growth factor alpha receptor,Platelet-derived growth factor receptor 2 (PDGFR-2),CD140a,PDGFR2,RHEPDGFRA,PDGFRA
产品介绍 评论(0)
宿主来源
Human抗原名称
PDGFRα分子别名
Platelet-derived growth factor receptor alpha; PDGF-R-alpha; PDGFR-alpha; Alpha platelet-derived growth factor receptor; Alpha-type platelet-derived growth factor receptor; CD140 antigen-like family member A; CD140a antigen; Platelet-derived growth factor alpha receptor; Platelet-derived growth factor receptor 2 (PDGFR-2); CD140a; PDGFR2; RHEPDGFRA; PDGFRA细胞定位
Cell membraneAccession
P16234抗体类型
Recombinant mAb抗体同种型
IgG1,k反应种属 ?
Hu纯化方式
Protein A浓度
5 mg/ml内毒素含量
<1EU/mg标记
Unconjugated性状
Liquid缓冲体系
PBS pH7.4, containing no preservative
储存条件
2 to 8 °C for 2 weeks under sterile conditions;
-20 °C for 3 months under sterile conditions;
-80 °C for 24 months under sterile conditions.
Please avoid repeated freeze-thaw cycles.应用
Blocking of Mesothelin signaling Functional assays
WB
稀释度
应用 稀释度 推荐种属 WB 1:1000 Hu
CD140a (also called platelet-derived growth factor receptor-alpha, PDGFR-α) is a 170-kDa glycosylated cell-surface receptor tyrosine kinase encoded by the PDGFRA gene, featuring an extracellular ligand-binding region with five immunoglobulin-like domains, a single transmembrane segment and an intracellular split tyrosine-kinase domain; upon binding PDGF-AA, -AB or -BB it forms homo- or heterodimers, triggers downstream signalling cascades that drive proliferation, migration and differentiation of mesenchymal and glial cells, and is indispensable for embryogenesis of kidney, testis and other organs, wound healing and maintenance of hematologic tissues, while PDGFRA mutations or amplifications are linked to clonal hypereosinophilic neoplasms, gastrointestinal stromal tumours, gliomas and hepatocellular carcinoma, making CD140a a potential therapeutic target in these cancers .
免疫印迹
WB result of Anti-Human PDGFRα Monoclonal Antibody (Olaratumab)
Primary antibody: Anti-Human PDGFRα Monoclonal Antibody (Olaratumab) at 1/1000 dilution
Lane 1: PDGF R alpha/PDGFRA His Tag Protein, Human lysate 1 µg
Secondary antibody: Goat Anti-Human IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 80 kDa
Observed MW: 80 kDa
ELISA
Immobilized PDGF R alpha/PDGFRA His Tag Protein, Human (UA010720) can bind Olaratumab. The EC50 for this effect is 2.717 ng/mL.







评论(0)